Diagnostics Innovations
Neelyx Labs addresses healthcare’s biggest challenges by developing innovative diagnostic solutions.
We utilize our unique in-house expertise to help bring research and development into clinical practice.
We advance the field of biotechnology with our focuses in key areas such as polymerase chain reaction and next generation sequencing.
We create new high-and low-complexity tests using our wide-ranging knowledge and experience.
We design and execute clinical trials, protocols, and performance evaluations for new testing products.
We transform products and technologies into highly efficient, accurate, and cost-effective solutions.
We develop technology that is open-source and open-platform, making it broadly available and accessible to others in science and healthcare.
utilize · advance · create · design & execute · transform · develop
HIGH-COMPLEXITY LABORATORY DIAGNOSTICS
Neelyx Labs is ready and able to take your cutting-edge molecular diagnostic technologies from the research laboratory to clinical practice.
Examples of high-complexity technologies we work with:
Polymerase Chain Reaction (PCR)
Small RNA/ miRNA
Next Generation Sequencing (NGS)
Transcriptomics
Genomics
Pharmacogenomics (PGX)
Polygenic Risk Scores (PRS)
Looking to collaborate on a high-complexity technology not listed here?
Key achievement in high-complexity diagnostics:
NEXT GENERATION SEQUENCING
Neelyx Labs created one of the earliest diagnostic COVID-19 sequencing methods in the world: our OpenSeq COVID-19 Variant Test.
LOW-COMPLEXITY POINT-OF-CARE & AT-HOME TESTING
Neelyx Labs has the necessary experience to design and execute clinical trials and performance evaluations to bring your point-of-care tests and at-home test kits to market.
Examples of our specialties in low-complexity testing:
Lateral Flow Antigen & Antibody Testing
Serology Testing
Molecular At-Home Test Kit Development
Looking to collaborate on a low-complexity testing method not listed here?
Key achievement in low-complexity testing:
LATERAL FLOW ANTIGEN TESTING
The SalivaStick rapid test, developed by Neelyx Labs, was the first saliva-based antigen test for COVID-19 available in the United States.
OPEN-SOURCE, OPEN-PLATFORM TECHNOLOGY
Neelyx Labs can invent or super-charge your existing clinical methods and technology to improve the efficiency of your laboratory.
Examples of areas of science that benefit from our technologies:
Microbiology
Biochemistry
Multiplex PCR
Molecular Diagnostics
Looking to collaborate on bringing our technology to an area not listed here?
MULTIPLEX PCR
The highest throughput RT-PCR methodology was designed and validated at Neelyx Labs and is available as part of the SalivaDirect EUA.